INTRODUCTION
Staphylococcus aureus (SA) is a common pathogenic bacterium that leads to hospitalacquired (HA) and community-acquired (CA) infections mainly including skin and soft tissue infections (SSTIs) (DeLeo et al., 2010; Mithoe et al., 2012; Zhao et al., 2012) and severe fatal diseases such as endocarditis, necrotic pneumonia, severe bacteremia, and toxic shock syndrome. CA-SA is the primary pathogenic bacterium of SSTIs treated in emergency departments (Chen et al., 2010; DeLeo et al., 2010; Mithoe et al., 2012; Zhao et al., 2012) . Although HA-SA has been extensively investigated (Liu et al., 2009; Chen et al., 2010; Wu et al., 2010; Mithoe et al., 2012) , studies on CA-SA, particularly CA-SA-caused SSTIs in adults, are rare (Wu et al., 2010; Zhao et al., 2012) . Some researchers have hypothesized that methicillinresistant SA (MRSA) is caused by the transfer of Staphylococcus cassette chromosome mec (SCCmec) to methicillin-susceptible SA (MSSA) (Lindsay and Holden, 2006; Pandian et al., 2011) . Therefore, investigating the molecular structure and genetic makeup of CA-MSSA is of great significance for understanding CA-MRSA formation. In addition, virulence factors play an important role in CA-SA infections (Kaltsas et al., 2011; Khokhlova et al., 2012) , such as Panton-Valentine leukocytic toxin (PVL), toxic shock syndrome toxin-1 (TSST-1), staphylococcal enterotoxin C (SEC), staphylococcal enterotoxin H (SEH), staphylococcal exfoliative toxins (ET), and so on.
In this study, we summarized the clinical features, epidemiological distribution, molecular characteristics, and drug resistance of 55 CA-SA-caused SSTIs treated at our hospital. The aims of the study were to elucidate the incidence, drug resistance phenotypes, risk factors, toxigene carrying rate, and molecular characteristics of CA-MSSA, and thus to provide laboratory data for the treatment of CA-MSSA-caused infections.
MATERIAL AND METHODS

Case selection and strain collection
Patients with CA purulent SSTI that received treatment at the dermatology, outpatient, and emergency departments of our hospital were enrolled in the study. Strains were primarily obtained through isolation from the selected cases between January 2009 and August 2010. The quality-controlled strains were SA ATCC29213 and Enterococcus faecalis ATCC29212. This study was conducted in accordance with the declaration of Helsinki and with approval from the Ethics Committee of the First Affiliated Hospital of the Chinese People's Liberation Army General Hospital. Written informed consent was obtained from all participants.
Strain identification
Preliminary identification was performed based on bacterial morphology, Gram staining, hemolysis, and catalase tests. Then, Slidex Staph Plus latex agglutination was performed for rapid detection; agglutinating bacteria that could be visually observed within 30 s were determined to be SA. Questionable bacteria were further identified using the API and VITEK systems.
Antibacterial sensitivity test
The minimal inhibitory concentrations (MICs) of 18 antibacterials for 12 SA strains were determined using agar dilution based on the Clinical and Laboratory Standards Institute M100-S20 2010 criteria proposed by the National Committee for Clinical Laboratory Standards (Clinical and Laboratory Standards Institute, 2010). The antibacterials for the determination of sensitivity, mesomerisms, and drug resistance included oxacillin (Sigma Chemical; St. Louis, MO, USA), cefoxitin (FOX; Sigma Chemical), teicoplanin (Sanofiaventis; Schiltigheim, France), vancomycin (Eli Lilly; Indianapolis, IN, USA), erythromycin (ERY; Sigma Chemical), clindamycin (CLI; Sigma Chemical), tetracycline (TCY), chloramphenicol (Sigma Chemical), gentamicin (GEN; Sigma Chemical), sulfamethoxazole + trimethoprim (Sigma Chemical), rifampicin (Sigma Chemical), levofloxacin (LVX; Daiichi Pharmaceutical; Tokyo, Japan), tigecycline (Pfizer Pharmaceutical; New York, NY, USA), linezolid (Pfizer), cephazolin (Sigma Chemical), cefuroxime (Sigma Chemical), ceftriaxone (Sigma Chemical), and mupirocin (Sigma Chemical). The breakpoint of tigecycline was that proposed by the American Food and Drug Administration (S ≤ 0.5 μg/mL).
MRSA detection
The isolated SA strains were detected using the oxacillin MIC method and mecA and femB duplex polymerase chain reactions (PCRs) (Sun et al., 2012; Zhao et al., 2012) . The duplex PCR conditions consisted of 94°C for 4 min, 30 cycles of 94°C for 45 s, 50°C for 45 s, and 72°C for 60 s, and a final step at 72°C for 2 min. The electrophoresis strips of mecA and femB were respectively located at 310 and 651 bp. If both strips showed positive results, the strain was determined to be MRSA. If only mecA was positive, the strain was judged as methicillin-resistant coagulase-negative staphylococci (MRSCN). If only femB was positive, the strain was judged as MSSA.
CA-SA molecular typing
SCCmecA typing, staphylococcal protein A (SPA) typing, and multilocus sequence typing (MLST) were performed using PCR according to the literature (Rodríguez-Baño et al., 2009; Escobar et al., 2012; Sun et al., 2012; Zhao et al., 2012) . The seven housekeeping genes for MLST amplification were arc (673 bp), aroe (568 bp), glpf (635 bp), gmk (548 bp), pta (584 bp), tpi (512 bp), and yqil (654 bp). Strain MLST was determined, and the genetic relationships among different primary clones were analyzed according to the Allelic Profiles software. The primer sequences for SPA typing were: 5ꞌ-TAAAGACGATCCTTCGGYGAGC-3ꞌ (spa113f) and 5ꞌ-CAGCAGTAGTGCCGTTTGCTT-3ꞌ (spa1514f). The PCR conditions consisted of 95°C for 5 min, 30 cycles of 95°C for 45 s, 60°C for 45 s, and 72°C for 90 s, and a final step at 72°C for 10 min. A single strip between 300 and 400 bp was considered to be positive. Forward sequencing was primarily performed using the spa113f primer. The obtained spa sequencing outcomes were compared with those in the typing database (http://spa.ridom.de/ repeats.shtml).
Virulence-related gene detection
The virulence-related genes encoding PVL, TSST-1, SEC, SEH, and ET were amplified using PCR based on methods provided in the literature (Chen et al., 2009; Kaltsas et al., 2011; Khokhlova et al., 2012; Zhao et al., 2012) . The target genes were 433 bp for PVL, 350 bp for TSST-1, 257 bp for SEC, 375 bp for SEH, and 119 bp for ET.
Statistical analysis
Drug susceptibility data were analyzed for drug resistance patterns using the WHO-NET-5.6 software and the interpretation of breakpoints was based on the guidelines of the Clinical and Laboratory Standards Institute. Data batch processing and integration were performed using the Microsoft Office and Filemaker database softwares.
RESULTS
Clinical and microbiological characteristics of SSTIs
A total of 55 SSTIs were investigated in this study. Among the recruited patients, 10 were male (62.5%). The patients ranged in age from 19 to 62 years with an average age of 32.2 ± 11.6 years. Among the infections, there were 10 skin infections, 6 phlegmons, 5 festers, 5 furuncles, 8 folliculitises, 8 Tinea skin infections, 6 abscesses, and 7 other SSTIs. A total of 12 SA strains, 27 coagulase-negative Staphylococcus strains, and 15 other pathogenic strains were isolated. All of the strains were verified and confirmed using the API 20E or VITEK2 Compact automatic system.
CA-SA drug susceptibility patterns and duplex PCR outcomes
No MRSA was observed among the 12 strains of SA (FOX > 8 μg/mL). CA-SA showed high resistance rates to ERY, CLI, TCY, GEN, and LVX (50, 25, 25, 8.3, and 8.3%, respectively) ; it showed susceptibility to the remaining 13 drugs tested (100%). The results of CA-SA drug susceptibility are summarized in Table 1 . Duplex PCR only showed positive femB results. Thus, CA-MSSA was defined. 
Epidemiological analysis of Staphylococcus aureus infection
MLST and SPA typing of CA-MSSA
A total of 10 MLST-based types and 8 SPA-based types were confirmed in CA-MSSA, which belonged to 9 types of clonal complexes. The clones included ST5-t002-CC5 (2 strains), ST22-t309-CC22 (2 strains), ST398-t034-CC398 (1 strain), ST15-t5864-CC15 (1 strain), ST7-t091-CC7 (1 strain), ST25-t078-CC25 (1 strain), ST30-t318-CC30 (1 strain), ST121-t1425-CC121 (1 strain), ST800-t1425-CC121 (1 strain), and ST630-t377-CC8 (1 strain). The distribution of MLST-and SPA-based CA-MSSA types are shown in Figure 1 and Table 2 . Table 2 . Molecular characteristics of 12 isolated CA-MSSA strains. P = positive; N = negative.
Virulence genes
The pvl gene was detected in 4 strains of CA-MSSA (33.3%), the sec gene was found in 3 strains (25%), and the tsst-1 gene was found in one strain (8.3%). The pvl, sec, and tsst-1 genes were found coexisting in one strain, and another strain showed the coexistence of the pvl and sec genes (Table 2) .
